Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Romiplostim Improves Platelet Recovery after UCB Transplant

Georgios E. Christakopoulos, MD, Todd E. DeFor, MS, Stefanie M Hage, RN, John E. Wagner, MD, Michael A. Linden, MD PhD, Claudio G Brunstein, MD PhD, Nelli Bejanyan, MD, Michael R Verneris, MD, Angela R. Smith, MD MS

Blood (2019) 134 (Supplement_1): 1979.

https://doi.org/10.1182/blood-2019-125424

Published: 2019

Journal Articles

Preliminary Results of a Phase 1/2 Clinical Study of Zinc Finger Nuclease-Mediated Editing of BCL11A in Autologous Hematopoietic Stem Cells for Transfusion-Dependent Beta Thalassemia

Angela R. Smith, MD MS, Gary J. Schiller, MD, Gregory M Vercellotti, MD, Janet L. Kwiatkowski, MD MSCE, Lakshmanan Krishnamurti, MD, Erica B. Esrick, MD, David A. Williams, MD, Weston P. Miller, MD, Adrian Woolfson, MD PhD, Mark C. Walters, MD

Blood (2019) 134 (Supplement_1): 3544.

https://doi.org/10.1182/blood-2019-125743

Published: 2019

Journal Articles

Reduced Toxicity Conditioning Is Better Tolerated but Has Higher Graft Failure Compared to Myeloablative Conditioning in Children with Inherited Metabolic Disorders

Michael Downey, BA, Ashish O. Gupta, MBBS, MPH, Ryan Shanley, M.S, Weston P. Miller, MD, Paul Orchard, MD, Angela R. Smith, MD MS

Blood (2018) 132 (Supplement 1): 3352.

https://doi.org/10.1182/blood-2018-99-117573

Published: 2018

Journal Articles

Immune Mediated Cytopenias Following Allogeneic Hematopoietic Cell Transplantation for Non-Malignant Disease: Risk Factors and Treatment Response in the Pediatric Population

Robert T. Galvin, MD, Qing Cao, MS, Weston P. Miller, MD, Angela R. Smith, MD MS, Christen L. Ebens, MD MPH

Blood (2018) 132 (Supplement 1): 3377.

https://doi.org/10.1182/blood-2018-99-117718

Published: 2018

Journal Articles

Final Analysis of Day +100 Survival By Prior Hematopoietic Stem Cell Transplant Type from an Expanded Access Study of Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome

Paul G Richardson, MD, Angela R. Smith, MD MS, Brandon Triplett, MD, Nancy Kernan, MD, Leslie Lehmann, MD, Robert J. Ryan, Robin L. Hume, MS, William Martin Tappe, MD, Stephan A Grupp, MD PhD

Blood (2017) 130 (Supplement 1): 3224.

https://doi.org/10.1182/blood.V130.Suppl_1.3224.3224

Published: 2017

Journal Articles

Pooled Analysis of Day +100 Survival for Defibrotide-Treated Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) and Ventilator or Dialysis Dependence Following Hematopoietic Stem Cell Transplantation (HSCT)

Paul G Richardson, MD, Angela R. Smith, MD MS, Nancy A. Kernan, MD, Joseph H. Antin, MD, Leslie Lehmann, MD, Robert J. Ryan, Robin L. Hume, MS, William Martin Tappe, MD, Stephan A Grupp, MD PhD

Blood (2017) 130 (Supplement 1): 1946.

https://doi.org/10.1182/blood.V130.Suppl_1.1946.1946

Published: 2017

Journal Articles

Efficacy and Safety of Defibrotide in Pediatric Patients with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results from the Expanded-Access Program

Nancy A. Kernan, MD, Angela R. Smith, MD MS, Brandon Triplett, MD, Leslie Lehmann, MD, Robert J. Ryan, Wei Liang, Robin L. Hume, MS, William Martin Tappe, MD, Stephan A Grupp, MD PhD

Blood (2017) 130 (Supplement 1): 1948.

https://doi.org/10.1182/blood.V130.Suppl_1.1948.1948

Published: 2017

Journal Articles

Validation of a Modified Comorbidity Index for Allogeneic Hematopoietic Cell Transplant

Todd E. DeFor, MS, Chap Le, PhD, Angela R Smith, MD MS, Erica D. Warlick, MD, Nelli Bejanyan, MD, Daniel J. Weisdorf, MD

Blood (2016) 128 (22): 1167.

https://doi.org/10.1182/blood.V128.22.1167.1167

Published: 2016

Journal Articles

Outcomes after Donor Lymphocyte Infusion for Insufficient Donor Chimerism Following Hematopoietic Cell Transplantation for Non-Malignant Disorders

Carter Biewen, BA, Angela R Smith, MD MS, Jakub Tolar, MD, PhD, Weston P Miller, IV, MD

Blood (2015) 126 (23): 1969.

https://doi.org/10.1182/blood.V126.23.1969.1969

Published: 2015

Journal Articles

Early Initiation of Defibrotide in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation Improves Day +100 Survival

Paul G. Richardson, MD, Angela R. Smith, MD MS, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Stephan A. Grupp, MD PhD, Joseph H. Antin, MD, Leslie E. Lehmann, MD, Maja Miloslavsky, PhD, Robin L. Hume, MS, Alison L. Hannah, MD, Bijan Nejadnik, MD, Robert J. Soiffer, MD

Blood (2015) 126 (23): 4311.

https://doi.org/10.1182/blood.V126.23.4311.4311

Published: 2015

Journal Articles

The Impact of Graft/Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Non-Malignant Disease

Matthew R Kudek, MD, Ryan Shanley, MS, Nicole D. Zantek, MD, PhD, Angela R. Smith, MD MS, Weston P Miller, IV, MD

Blood (2015) 126 (23): 4369.

https://doi.org/10.1182/blood.V126.23.4369.4369

Published: 2015

Journal Articles

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial

Blood (2015) 126 (23): 737.

https://doi.org/10.1182/blood.V126.23.737.737

Published: 2015

Journal Articles

Updated Results from a Large, Ongoing, Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease

Paul G. Richardson, Angela R. Smith, MD MS, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Stephan A. Grupp, MD PhD, Sally Arai, MD, Joseph H. Antin, MD, Leslie E. Lehmann, MD, Valeria Bandiera, Robin L. Hume, MS, Alison L. Hannah, MD, Bijan Nejadnik, MD, Robert J. Soiffer, MD, Defibrotide Study Group

Blood (2014) 124 (21): 2470.

https://doi.org/10.1182/blood.V124.21.2470.2470

Published: 2014

Journal Articles

Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study

Daniel Pease, MD, Julie A Ross, PhD, Phuong L. Nguyen, MD, Betsy Hirsch, PhD, Adina Cioc, MD, Angela R. Smith, MD, MS, Michelle A. Roesler, Rachel K. Fonstad, M.S., Erica D. Warlick, MD

Blood (2013) 122 (21): 2798.

https://doi.org/10.1182/blood.V122.21.2798.2798

Published: 2013

Journal Articles

Results Of The Large Prospective Study On The Use Of Defibrotide (DF) In The Treatment Of Hepatic Veno-Occlusive Disease (VOD) In Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome - Updated Results Of a Treatment IND (T-IND) Expanded Access Protocol

Blood (2013) 122 (21): 700.

https://doi.org/10.1182/blood.V122.21.700.700

Published: 2013

Journal Articles

Higher CSA Levels After Umbilical Cord Blood Transplant For Acute Leukemia Result In Improved Survival

Heather E Stefanski, MD, PhD, Michael J Burke, MD, Qing Cao, MS, Angela R. Smith, MD, MS, Margaret L. MacMillan, MD, Erica D. Warlick, MD, Daniel J. Weisdorf, MD, John E. Wagner, MD, Michael R. Verneris, MD

Blood (2013) 122 (21): 2097.

https://doi.org/10.1182/blood.V122.21.2097.2097

Published: 2013

Journal Articles

Family History Of Hematologic Malignancies and Disorders In a Population Based Study Of Myelodysplastic Syndromes (MDS)

Angela R. Smith, MD, MS, Erica D. Warlick, MD, Rachel K. Fonstad, M.S., Michelle A. Roesler, Jenny N. Poynter, PhD, Betsy Hirsch, PhD, Phuong L. Nguyen, MD, Adina Cioc, MD, Julie A Ross, PhD

Blood (2013) 122 (21): 1541.

https://doi.org/10.1182/blood.V122.21.1541.1541

Published: 2013

Journal Articles

Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol

Blood (2011) 118 (21): 487.

https://doi.org/10.1182/blood.V118.21.487.487

Published: 2011

Journal Articles

What Is the Role of Red Blood Cell Transfusion Threshold on Number of Transfusions in Pediatric Patients After Hematopoietic Stem Cell Transplant?

Rachel S. Bercovitz, M.D., Andrew C. Dietz, M.D., M.S., Rhamy N. Magid, M.D., Nicole D. Zantek, M.D., Ph.D., Angela R. Smith, MD, MS, Ralph R. Quinones, M.D.

Blood (2011) 118 (21): 1263.

https://doi.org/10.1182/blood.V118.21.1263.1263

Published: 2011

NARROW

Romiplostim Improves Platelet Recovery after UCB Transplant

Preliminary Results of a Phase 1/2 Clinical Study of Zinc Finger Nuclease-Mediated Editing of BCL11A in Autologous Hematopoietic Stem Cells for Transfusion-Dependent Beta Thalassemia

Reduced Toxicity Conditioning Is Better Tolerated but Has Higher Graft Failure Compared to Myeloablative Conditioning in Children with Inherited Metabolic Disorders

Immune Mediated Cytopenias Following Allogeneic Hematopoietic Cell Transplantation for Non-Malignant Disease: Risk Factors and Treatment Response in the Pediatric Population

Final Analysis of Day +100 Survival By Prior Hematopoietic Stem Cell Transplant Type from an Expanded Access Study of Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome

Pooled Analysis of Day +100 Survival for Defibrotide-Treated Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) and Ventilator or Dialysis Dependence Following Hematopoietic Stem Cell Transplantation (HSCT)

Efficacy and Safety of Defibrotide in Pediatric Patients with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results from the Expanded-Access Program

Validation of a Modified Comorbidity Index for Allogeneic Hematopoietic Cell Transplant

Outcomes after Donor Lymphocyte Infusion for Insufficient Donor Chimerism Following Hematopoietic Cell Transplantation for Non-Malignant Disorders

Early Initiation of Defibrotide in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation Improves Day +100 Survival

The Impact of Graft/Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Non-Malignant Disease

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial

Updated Results from a Large, Ongoing, Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease

Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study

Results Of The Large Prospective Study On The Use Of Defibrotide (DF) In The Treatment Of Hepatic Veno-Occlusive Disease (VOD) In Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome - Updated Results Of a Treatment IND (T-IND) Expanded Access Protocol

Higher CSA Levels After Umbilical Cord Blood Transplant For Acute Leukemia Result In Improved Survival

Family History Of Hematologic Malignancies and Disorders In a Population Based Study Of Myelodysplastic Syndromes (MDS)

Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol

What Is the Role of Red Blood Cell Transfusion Threshold on Number of Transfusions in Pediatric Patients After Hematopoietic Stem Cell Transplant?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only